Questa Capital

Questa Capital, established in 2016, is a U.S.-based investment firm specializing in healthcare venture growth equity. Headquartered in Washington D.C., the firm invests in early to late-stage healthcare and biotech companies across North America. Questa seeks disruptive business models that enhance care quality and efficiency, partnering with exceptional management teams to build innovative market leaders. They target investments of $10 million to $40 million per company, focusing on sectors such as healthcare services, technology, and medical devices.

Brian L. Butler

Vice President

Shawn Conway

COO

Ryan Drant

Founder and Managing Partner

Evans Grenier

Vice President

Joe Huang

Vice President of Finance

Sanghamithra Kalimi

Associate

Justin Kirkpatrick

Partner

David Liu

Associate

Steph Scott

Vice President

Bradley Sloan

Managing Partner

Eric Thakor

Vice President

43 past transactions

Bicycle Health

Venture Round in 2025
Bicycle Health is a virtual addiction medicine clinic focused on treating opioid dependence and use disorder. Established in 2017 in San Francisco, California, the company offers a telemedicine platform that connects patients with addiction medicine specialists for medical evaluations and follow-ups via phone and video calls. Patients can book appointments and receive electronic prescriptions that are sent to nearby pharmacies, with medications delivered directly to their homes. Bicycle Health collaborates with patients' insurance providers to facilitate reimbursement for services, positioning itself as a valuable resource for physicians and their patients while enhancing the patient-provider relationship.

Aerin Medical

Venture Round in 2025
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

OSSIO

Series D in 2024
Ossio is an orthopedic fixation company dedicated to enhancing the orthopedic experience for patients, healthcare providers, and payors. Established in 2014, the company focuses on developing innovative alternatives to traditional metal implants in the orthopedic fixation market, which is valued at over $10 billion. Their flagship product, OSSIOfiber, utilizes Intelligent Bone Regeneration Technology, offering a biocomposite material that is designed to support the natural healing process. This breakthrough platform allows for secure fixation while enabling the body to regenerate bone tissue, effectively replacing the implant without leaving any permanent material behind. Ossio's technology addresses the limitations of conventional bio-resorbable materials, providing the necessary mechanical strength for easy insertion and stable fixation, while promoting better healing outcomes for patients with orthopedic disorders.

ACTO

Venture Round in 2024
ACTO is a technology company specializing in an AI-powered SaaS platform for life sciences. It provides an omnichannel education solution, offering mobile learning experiences and administrative tools to enhance engagement and performance for field representatives. The platform ensures consistent brand messaging and easy access to crucial information through voice-enabled search and training materials.

Mindset Medical

Series A in 2024
Mindset Medical is a Health Care Company that develops a platform for clinical information. Through their platform physicians will understand patient pain, saves time for providers and patients, they eliminate paper and redundant forms, and allows providers more time for patients. Mindset Medical was founded in 2016 in Phoenix, Arizona.

SamaCare

Series B in 2024
SamaCare, Inc. is a technology company based in San Francisco, California, founded in 2017. It specializes in developing software that streamlines the prior authorization process for healthcare providers and pharmaceutical manufacturers regarding medically administered products. SamaCare's cloud-based workflow automation platform enhances the efficiency of specialty drug prior authorization, enrollment, and benefit verification, thereby helping medical practices navigate complex administrative tasks. The platform also includes features for building and submitting prior authorizations, as well as monitoring approvals and rejections, ultimately aimed at reducing the administrative burdens that can hinder patient care. Additionally, SamaCare offers premium services and data analytics to pharmaceutical brands, thereby improving access to essential therapies while ensuring compliance with regulations.

PocketHealth

Series B in 2024
PocketHealth is a cloud-sharing platform based in Toronto, Ontario, that facilitates the electronic sharing of medical imaging records between providers and patients. Founded in 2016, the platform allows patients to access their imaging results shortly after their scans and securely share this information with healthcare professionals, regardless of whether they are part of the PocketHealth network. By establishing a seamless and secure infrastructure, PocketHealth enhances the way sensitive medical imaging information is exchanged, improving accessibility and efficiency in patient care.

PatientFi

Venture Round in 2024
PatientFi, LLC operates a digital platform that facilitates financing for aesthetic medical procedures. Founded in 2017 and based in Irvine, California, the company allows patients to apply for credit online and collaborates with healthcare providers in elective sectors such as plastic surgery, dermatology, and dental care. Through its point-of-sale technology, PatientFi offers personalized financing plans, enabling patients to afford procedures like breast augmentation, mommy makeovers, and surgical facial rejuvenation. The company, previously known as PatientFirst Finance, aims to provide accessible financial solutions for those seeking health, beauty, and wellness treatments.

Avive

Venture Round in 2024
Avive Solutions is a company that develops an advanced Automated External Defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest (SCA). Their device is designed to be portable, affordable, and user-friendly, ensuring that anyone can effectively respond to an SCA incident. In addition to the AED, Avive offers a connected software platform that facilitates the transfer of critical incident data to emergency services and healthcare professionals, enhancing the overall response to cardiac emergencies. By addressing the challenges associated with SCA, Avive Solutions aims to empower individuals and organizations to save lives more effectively. The company is based in Brisbane, California.

Calyxo

Series D in 2023
Calyxo, Inc. is a medical device company established in 2016 that specializes in innovative solutions for patients suffering from kidney stones, a condition that significantly impacts healthcare resources. The company has developed a vacuum-assisted retrieval device that allows for the efficient removal of multiple kidney stone fragments in a single insertion, offering a quick and effective procedure for healthcare providers. This device aims to enhance patient outcomes by ensuring a stone-free result, thereby streamlining the treatment process. Calyxo is led by a team of experienced professionals with a strong background in urology, united by a commitment to improving kidney stone care through technological advancements.

Free Market Health

Series B in 2023
Free Market Health, founded in 2019 and based in Pittsburgh, PA, is a developer of a care-driven marketplace aimed at simplifying the complex specialty medication fulfillment process. The company offers a platform that enhances the efficiency of referral distribution and reimbursement, helping payers and specialty pharmacies navigate the intricacies of the healthcare landscape. By focusing on value drivers and accountabilities for patient referrals, Free Market Health enables timely access to lifesaving and life-altering medications. The company prioritizes the needs of all stakeholders, particularly patients, by optimizing resources and maximizing opportunities within the healthcare system.

Eximis Surgical

Venture Round in 2023
Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

Cortica

Series D in 2023
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

DispatchHealth

Venture Round in 2022
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

ACTO

Series B in 2022
ACTO is a technology company specializing in an AI-powered SaaS platform for life sciences. It provides an omnichannel education solution, offering mobile learning experiences and administrative tools to enhance engagement and performance for field representatives. The platform ensures consistent brand messaging and easy access to crucial information through voice-enabled search and training materials.

Calyxo

Series C in 2022
Calyxo, Inc. is a medical device company established in 2016 that specializes in innovative solutions for patients suffering from kidney stones, a condition that significantly impacts healthcare resources. The company has developed a vacuum-assisted retrieval device that allows for the efficient removal of multiple kidney stone fragments in a single insertion, offering a quick and effective procedure for healthcare providers. This device aims to enhance patient outcomes by ensuring a stone-free result, thereby streamlining the treatment process. Calyxo is led by a team of experienced professionals with a strong background in urology, united by a commitment to improving kidney stone care through technological advancements.

Aerin Medical

Private Equity Round in 2022
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

Proximie

Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.

Socially Determined

Series B in 2022
Socially Determined, Inc. develops a risk intelligence platform focused on social determinants of health (SDOH). Its primary offering, SocialScape, provides insights into social risks through a combination of social risk indices and visualizations derived from diverse data sources. This platform enables organizations, including health plans, providers, life science companies, and government agencies, to understand the dynamics of social risk and implement actionable programs aimed at enhancing health outcomes while reducing costs. Founded in 2017 and headquartered in Washington, D.C., Socially Determined utilizes secure, cloud-based technology to analyze and visualize community and individual SDOH risks, allowing clients to tailor their intervention strategies to address the specific needs of socially and clinically complex patients.

Bicycle Health

Series B in 2022
Bicycle Health is a virtual addiction medicine clinic focused on treating opioid dependence and use disorder. Established in 2017 in San Francisco, California, the company offers a telemedicine platform that connects patients with addiction medicine specialists for medical evaluations and follow-ups via phone and video calls. Patients can book appointments and receive electronic prescriptions that are sent to nearby pharmacies, with medications delivered directly to their homes. Bicycle Health collaborates with patients' insurance providers to facilitate reimbursement for services, positioning itself as a valuable resource for physicians and their patients while enhancing the patient-provider relationship.

PocketHealth

Series A in 2022
PocketHealth is a cloud-sharing platform based in Toronto, Ontario, that facilitates the electronic sharing of medical imaging records between providers and patients. Founded in 2016, the platform allows patients to access their imaging results shortly after their scans and securely share this information with healthcare professionals, regardless of whether they are part of the PocketHealth network. By establishing a seamless and secure infrastructure, PocketHealth enhances the way sensitive medical imaging information is exchanged, improving accessibility and efficiency in patient care.

Avive

Series A in 2022
Avive Solutions is a company that develops an advanced Automated External Defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest (SCA). Their device is designed to be portable, affordable, and user-friendly, ensuring that anyone can effectively respond to an SCA incident. In addition to the AED, Avive offers a connected software platform that facilitates the transfer of critical incident data to emergency services and healthcare professionals, enhancing the overall response to cardiac emergencies. By addressing the challenges associated with SCA, Avive Solutions aims to empower individuals and organizations to save lives more effectively. The company is based in Brisbane, California.

VyncaCare

Series C in 2022
VyncaCare provides palliative care, advanced care planning, and enhanced care management services.

Cortica

Series C in 2021
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Bicycle Health

Series A in 2021
Bicycle Health is a virtual addiction medicine clinic focused on treating opioid dependence and use disorder. Established in 2017 in San Francisco, California, the company offers a telemedicine platform that connects patients with addiction medicine specialists for medical evaluations and follow-ups via phone and video calls. Patients can book appointments and receive electronic prescriptions that are sent to nearby pharmacies, with medications delivered directly to their homes. Bicycle Health collaborates with patients' insurance providers to facilitate reimbursement for services, positioning itself as a valuable resource for physicians and their patients while enhancing the patient-provider relationship.

Proximie

Series B in 2021
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.

Claritas Rx

Private Equity Round in 2021
Claritas Rx LLC is a digital health data company based in San Francisco, California, founded in 2011. It specializes in developing a platform that automates and integrates channel, commercial, and clinical data for biopharmaceutical manufacturers. The company focuses on providing data integration and analytics solutions that enable pharmaceutical companies to derive actionable insights into their commercial strategies and operational improvements. By leveraging its proprietary technology and extensive industry expertise, Claritas Rx aims to enhance the patient experience beyond clinical trials, helping manufacturers identify variables that influence patient access, treatment duration, and behavioral trends.

DispatchHealth

Series D in 2021
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Eko Health

Series C in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

ControlRad

Series C in 2020
ControlRad is focused on creating innovative solutions aimed at significantly reducing radiation exposure risks associated with both fixed and mobile C-arm procedures for patients and healthcare professionals. The company's devices are designed to minimize ionizing radiation during fluoroscopically guided interventional procedures, ensuring that image quality and workflow are not compromised. ControlRad employs an add-on solution for C-arms that utilizes an eye tracker and a tablet interface, allowing radiologists to achieve optimal image quality in the critical areas of interest while maintaining clarity in the surrounding regions. This approach enables healthcare providers to enhance patient safety without sacrificing the effectiveness of existing x-ray systems.

Aerin Medical

Venture Round in 2020
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

DispatchHealth

Series C in 2020
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Eximis Surgical

Series A in 2020
Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

Cortica

Venture Round in 2020
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

ControlRad

Series B in 2019
ControlRad is focused on creating innovative solutions aimed at significantly reducing radiation exposure risks associated with both fixed and mobile C-arm procedures for patients and healthcare professionals. The company's devices are designed to minimize ionizing radiation during fluoroscopically guided interventional procedures, ensuring that image quality and workflow are not compromised. ControlRad employs an add-on solution for C-arms that utilizes an eye tracker and a tablet interface, allowing radiologists to achieve optimal image quality in the critical areas of interest while maintaining clarity in the surrounding regions. This approach enables healthcare providers to enhance patient safety without sacrificing the effectiveness of existing x-ray systems.

andros

Series B in 2019
Andros is an NCQA certified credentialing and provider data management solution that integrates software and services to enhance efficiency in the healthcare sector. The company provides its clients with significant improvements in credentialing processes, boasting a tenfold reduction in turnaround times and a fifteenfold increase in overall efficiency compared to industry norms. Andros aims to assist payers and provider organizations in mitigating compliance risks, streamlining operations, and enhancing the management of their provider networks, ultimately contributing to more effective healthcare delivery.

DispatchHealth

Series B in 2019
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Barricaid

Series E in 2019
Barricaid is a medical device company that focuses on developing innovative solutions to prevent repeat disc herniation in patients who have undergone back surgery. The company's flagship product is a bone-anchored implant designed to reduce the likelihood of reherniation and the need for reoperation in cases involving large annular defects. This implant physically blocks the annulus at the surgical defect, enhancing the surgical outcome for patients at high risk of complications after lumbar discectomy. Composed of a titanium alloy, the device securely anchors into the vertebral body, either caudally or cranially, ensuring stability and effectiveness. By addressing the challenges associated with post-surgical recovery, Barricaid aims to improve patient outcomes and reduce the incidence of further surgeries related to sciatica.

Cortica

Venture Round in 2018
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Eximis Surgical

Venture Round in 2018
Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

DispatchHealth

Venture Round in 2017
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Medrio

Venture Round in 2017
Medrio, Inc. is a medical software company specializing in web-based electronic data capture solutions for clinical research. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Pune, India, and Paris, France, Medrio offers a comprehensive platform that supports clinical trials across all phases, including outcomes research, registries, and retrospective chart reviews. Its software facilitates various processes such as study design, data collection, management reporting, and statistical analysis, allowing users to efficiently manage their clinical research projects through a user-friendly web interface. Medrio serves a diverse clientele, including pharmaceutical and biotechnology companies, contract research organizations (CROs), academic institutions, and other research entities, with a focus on delivering faster, cost-effective solutions for complex clinical trials.

EPIX Therapeutics

Venture Round in 2017
EPIX Therapeutics, Inc. is a medical device company based in Santa Clara, California, specializing in the development of advanced temperature-sensing irrigated radiofrequency ablation catheters for the treatment of atrial fibrillation and other cardiac arrhythmias. Utilizing its proprietary TempaSure technology, which incorporates microwave radiometry, EPIX Therapeutics provides precise real-time feedback on volumetric temperature during ablation procedures. This technology enables physicians to control and predict lesion formation more accurately, ultimately enhancing clinical outcomes for patients. Founded in 2007 and previously known as Advanced Cardiac Therapeutics, EPIX Therapeutics has formed strategic partnerships with industry leaders such as Abbott Laboratories and Hansen Medical Inc. The company operates as a subsidiary of Medtronic plc, focusing on improving the treatment of irregular heart rhythms through its innovative catheter-based systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.